Organovo Holdings, Inc.
ONVO
Classement en actions
#36072
Organovo Holdings, Inc. is a biotechnology firm that specializes in engineering... Organovo Holdings, Inc. is a biotechnology firm that specializes in engineering sophisticated 3D tissues designed to accurately mimic critical facets of human diseases. Central to its operations is a comprehensive 3D human tissue platform, which features the company's proprietary NovoGen Bioprinters. These automated devices are crucial for fabricating complex, living 3D tissues from mammalian cells. The platform also includes supporting technologies necessary for creating specialized "bio-inks" and for the bioprinting of multi-cellular tissues with intricate structures. Organovo supplies specific products, such as ExVive human liver tissue and ExVive human kidney tissue, which are employed for predictive preclinical evaluation of investigational drug compounds. The company was founded in 2007 and maintains its corporate headquarters in Solana Beach, California.
Prix de l'action
$2.00
Dernière synchronisation: 2025-05-19
Capitalisation boursière
$2.93M
Changement (1 jour)
-3.38%
Changement (1 an)
656.14%
Pays
US
Échange Organovo Holdings, Inc. (ONVO)
Catégorie
Healthcare
Ratio P/S pour Organovo Holdings, Inc. (ONVO)
Ratio P/S au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Organovo Holdings, Inc., le ratio cours/ventes actuel (TTM) est 0. À la fin de 2026, le ratio P/S était de 0.
Historique du ratio P/S pour Organovo Holdings, Inc. de 2026 à 2026
Ratio P/S à la fin de chaque année
| Année | Ratio P/S | Changez |
|---|---|---|
| Pas assez de données pour les dates fournies. | ||
Ratio P/S pour des entreprises similaires ou concurrentes
| Entreprise | Ratio P/S | Différence de Ratio P/S | Pays |
|---|---|---|---|
| 10.02 | - |
US
|
|
| 40.55 | - |
US
|
|
| 3.96 | - |
AU
|
|
| - | - |
CH
|
|
| 10.15 | - |
NL
|
